CS logo
small CS logo
Southern Medical Day Care Centre

Wollongong, New South Wales, Australia
Cancer treatment center in New South Wales
57 Urunga Parade, Wollongong NSW 2500

About Southern Medical Day Care Centre


"A private day only hospital established to ensure optimum patient comfort. Our highly-qualified nursing staff provides constant supervision. We have been providing excellence in service to Wollongong and surrounds since 1998. The healthcare facility incorporates free-standing office spaces and a day-care treatment centre, with special treatment chairs and private rooms available. The facility is staffed by oncology-specialist nursing staff and has been established to provide optimum patient care for cancer patients in and around Wollongong."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Southern Medical Day Care Centre


During the past decade, Southern Medical Day Care Centre conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 9 clinical trials were completed, i.e. on average, 29% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 7 clinical trials were completed. i.e. 35% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Southern Medical Day Care Centre" #1 sponsor was "Merck Sharp & Dohme LLC" with 4 trials, followed by "Incyte Corporation" with 3 trials sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 33 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Medical Day Care Centre" #1 collaborator was "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator and "Alchemia Oncology" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

Clinical Trials Conditions at Southern Medical Day Care Centre


According to Clinical.Site data, the most researched conditions in "Southern Medical Day Care Centre" are "Melanoma" (3 trials), "Metastatic Colorectal Cancer" (3 trials), "Advanced Solid Tumors" (2 trials), "Breast Cancer" (2 trials) and "Non Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Southern Medical Day Care Centre" in a lesser frequency.

Clinical Trials Intervention Types at Southern Medical Day Care Centre


Most popular intervention types in "Southern Medical Day Care Centre" are "Drug" (37 trials), "Biological" (11 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Pembrolizumab" (9 trials), "Carboplatin" (5 trials), "Cisplatin" (3 trials) and "Epacadostat" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Southern Medical Day Care Centre


The vast majority of trials in "Southern Medical Day Care Centre" are 38 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Clinical Trials Status at Southern Medical Day Care Centre


Currently, there are NaN active trials in "Southern Medical Day Care Centre". undefined are not yet recruiting, 13 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Southern Medical Day Care Centre, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Southern Medical Day Care Centre, 9 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".